Verismo Therapeutics has filed a notice of an exempt offering of securities to raise $19,150,012.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Verismo Therapeutics is raising $19,150,012.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Bryan Kim played a key role…